Adverse effects of glucocorticoids have been abundantly reported. Published reports on low dose glucocorticoid treatment show that few of the commonly held beliefs about their incidence, prevalence, and impact are supported by clear scientific evidence. Safety data from recent randomised controlled clinical trials of low dose glucocorticoid treatment in RA suggest that adverse effects associated with this drug are modest, and often not statistically different from those of placebo.
- BMD, bone mineral density
- COBRA, combination treatment in early rheumatoid arthritis (trial)
- GC, glucocorticoid(s)
- GI, gastrointestinal
- NSAIDs, non-steroidal anti-inflammatory drugs
- RA, rheumatoid arthritis
- SLE, systemic lupus erythematosus
- rheumatoid arthritis
- adverse effects
Statistics from Altmetric.com
Published Online First 17 August 2005
Competing interest: None.